Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with or without trastuzumab (H) in patients (pts) with HER2-positive breast cancer
- Citation:
- J Clin Oncol vol 25 (18S) abstr 512
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- E. A. Perez E. H. Romond V. J. Suman J. Jeong N. E. Davidson C. E. Geyer Jr S. Martino E. P. Mamounas P. A. Kauffman N. Wolmark Ncctg/Nsabp
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: